Yüklüyor......

Effect of antiangiogenic therapy on tumor growth, vasculature and kinase activity in basal‐ and luminal‐like breast cancer xenografts

Several clinical trials have investigated the efficacy of bevacizumab in breast cancer, and even if growth inhibiting effects have been registered when antiangiogenic treatment is given in combination with chemotherapy no gain in overall survival has been observed. One reason for the lack of overall...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mol Oncol
Asıl Yazarlar: Lindholm, Evita M., Kristian, Alexandr, Nalwoga, Hawa, Krüger, Kristi, Nygård, Ståle, Akslen, Lars A., Mælandsmo, Gunhild M., Engebraaten, Olav
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2012
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5528356/
https://ncbi.nlm.nih.gov/pubmed/22521242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2012.03.006
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!